Advertisement

Topics

Agno Pharma Company Profile

18:37 EST 18th November 2017 | BioPortfolio

Agno Pharma is a global GMP compliant contract manufacturer jointly formed between Pharmalytica Services (a US-based company) and Keylab (a China-based company). Our mission is to provide timely and quality intermediates and APIs to our pharmaceutical and chemical clients throughout the world. Our company is founded upon our belief in the synergistic merger of US pharmaceutical manufacturing technologies, management, product registration and GMP compliance with China's economical manufacturing capabilities. This synergistic joint-venture allows us to provide the highest quality intermediates and GMP compliant APIs to our clients in a timely manner that is extremely cost competitive.
Our US partner, Pharmalytica Services, is an FDA-registered and DEA-licensed GMP compliant laboratory.
Pharmalytica Services has been providing outstanding GMP compliant laboratory and consulting services to major US and European pharmaceutical and chemical companies since the year 2000.
Our Chinese partner, Keylab, is an ISO 9001/14000 company. Keylab has been providing quality intermediates to US, European and Asian pharmaceutical and chemical companies since 1995

Location

683 N.Mountain Road
Newington
Connecticut
6111
United States of America

Contact

Phone: 1-860-953-2219
Fax: 1-860-953-2221
Email: info@agnopharma.com


News Articles [555 Associated News Articles listed on BioPortfolio]

Hebron Technology Co., Ltd. Announces Multiple Project Wins

WENZHOU, China, Aug. 22, 2017 /PRNewswire/ -- Hebron Technology Co., Ltd. ("Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the...

Fosun Pharma, Shanghai Pharma Bid for Arbor Pharma, Deal May Fetch $700 Million

  Life Sciences Jobs   ...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

#jobs #lifescience Assistant Controller – Pharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Assistant Controller – Pharma .NJ-Fort Lee, RESPONSIBILITIES: Kforce...

Technical Reports on Biotech Equities -- Vanda Pharma, ACADIA Pharma, Achillion Pharma, and ...

If you want a Stock Review on VNDA, ACAD, ACHN, or AGIO then come over to http://dailystocktracker.com/register/and sign up for your free customized report. Read more...

Why pharma engagement on twitter matters!

The fact that thousands of stakeholders chose to follow pharma accounts on twitter deserves our attention. It says that there are people out there genuinely interested in what pharma has ...

Despite lower interest & taxation, Marksans Pharma net dips by 26% in 2015─16

Marksans Pharma, a Rs. 890 crore plus pharma major related to Glenmark Pharmaceuticals, has failed to generate confidence among its investors.

#jobs #lifescience Director of Business Development – Biotech / Pharma, CRO’s

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Director of Business Development – Biotech / Pharma, CRO’s .CA-Sa...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.

Agnoprotein (Agno) is an important regulatory protein of JC virus (JCV), BK virus (BKV) and simian virus 40 (SV40) and these viruses are unable to replicate efficiently in the absence of this protein....

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Clinical Trials Series - Large Pharma.

AI-powered drug discovery captures pharma interest.

Clinical Trials [75 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [724 Associated Companies listed on BioPortfolio]

Agno Pharma

Agno Pharma is a global GMP compliant contract manufacturer jointly formed between Pharmalytica Services (a US-based company) and Keylab (a China-based company). Our mission is to provide timely and ...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

More Information about "Agno Pharma" on BioPortfolio

We have published hundreds of Agno Pharma news stories on BioPortfolio along with dozens of Agno Pharma Clinical Trials and PubMed Articles about Agno Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Agno Pharma Companies in our database. You can also find out about relevant Agno Pharma Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record